Drug Could Prolong Lives of Cancer Patients

Tools

By Alabama News Network

The drug erlotinib may help prolong the lives of patients with cervical cancer.

In a small trial, researchers gave 36 patients the drugs combined with chemo-radiation.

After three years, 80 percent were still alive and 73 percent had no disease progression. Researchers say larger studies are needed.  




This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

Poll

Should Alabama Allow TV Cameras in Courtrooms?

  • Yes
  • No

What's onFull Schedule

Hot Video From AP

AP Video